Oppenheimer Reiterates Perform Rating on Cellectar Biosciences (CLRB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Cellectar Biosciences, Inc. (NASDAQ: CLRB) | Delayed: 1.70 -0.08 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.78 | 52 Week High | $6.03 | |||
| Open | $1.79 | 52 Week Low | $0.41 | |||
| Day High | $1.79 | P/E | N/A | |||
| Day Low | $1.67 | EPS | $0.00 | |||
| Volume | 38,940 | |||||
